Seven Eight Capital LP Makes New Investment in Avantor, Inc. (NYSE:AVTR)

Seven Eight Capital LP purchased a new position in shares of Avantor, Inc. (NYSE:AVTR) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 30,295 shares of the company’s stock, valued at approximately $642,000.

A number of other institutional investors have also recently made changes to their positions in AVTR. CCLA Investment Management boosted its holdings in Avantor by 8.7% in the second quarter. CCLA Investment Management now owns 5,128,504 shares of the company’s stock worth $109,624,000 after acquiring an additional 408,360 shares in the last quarter. Vanguard Personalized Indexing Management LLC raised its position in shares of Avantor by 4.6% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 25,440 shares of the company’s stock valued at $539,000 after purchasing an additional 1,119 shares during the last quarter. Sargent Investment Group LLC acquired a new stake in Avantor in the 2nd quarter worth approximately $338,000. Quantbot Technologies LP purchased a new stake in Avantor during the 2nd quarter worth approximately $5,738,000. Finally, Dimensional Fund Advisors LP increased its stake in Avantor by 8.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,434,195 shares of the company’s stock valued at $94,018,000 after purchasing an additional 350,247 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Activity

In other news, CAO Steven W. Eck sold 3,525 shares of the company’s stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. The sale was disclosed in a filing with the SEC, which is available at this link. Company insiders own 1.50% of the company’s stock.

Avantor Stock Performance

Shares of NYSE AVTR opened at $26.99 on Friday. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $28.00. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59. The company’s fifty day moving average price is $25.04 and its 200 day moving average price is $24.36. The company has a market capitalization of $18.33 billion, a PE ratio of 69.21, a price-to-earnings-growth ratio of 2.75 and a beta of 1.32.

Avantor (NYSE:AVTR) last posted its earnings results on Friday, July 26th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. The firm had revenue of $1.70 billion for the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a return on equity of 12.40% and a net margin of 5.28%. On average, research analysts predict that Avantor, Inc. will post 1.01 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on AVTR shares. Evercore ISI lowered their price objective on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 2nd. Robert W. Baird boosted their price target on Avantor from $26.00 to $27.00 and gave the company an “outperform” rating in a research note on Monday, July 29th. Wells Fargo & Company assumed coverage on Avantor in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 price objective for the company. Morgan Stanley upped their target price on Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $31.00 price target on shares of Avantor in a research report on Monday, July 29th. Four research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $27.40.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.